Life-threatening vaginal bleeding after starting rivaroxaban treatment
Ugeskrift for Læger · 2024
DOI: 10.61409/v01240012 ↗Kurz gefasst
Fallbericht in der Zeitschrift Ugeskrift for Læger, 2024. Verfasst von Luna Fabricius Ekenberg und 2 weiteren Autor:innen. Beteiligte Einrichtung: Gynækologisk-Obstetrisk Afdeling, Slagelse Sygehus. Hauptthemen laut MEDLINE: Rivaroxaban, Factor Xa Inhibitors, Uterine Hemorrhage, Atrial Fibrillation. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
This is a case report of a 44-year-old premenopausal woman who was admitted to hospital due to uncontrollable and life-threatening vaginal bleeding after starting rivaroxaban treatment for atrial fibrillation. She had a medical history with menorrhagia due to an intrauterine fibroma. She did not respond sufficiently to factor X supplement or other non-surgical medical interventions. The bleeding subsided after bilateral embolization of aa. uterinae.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Gynækologisk-Obstetrisk Afdeling, Slagelse Sygehus.
Zitieren
APA
Ekenberg, L. F., Lindgren, L. M., & Pehrson, C. (2024). Life-threatening vaginal bleeding after starting rivaroxaban treatment. Ugeskrift for Læger. https://doi.org/10.61409/v01240012
Vancouver
Ekenberg LF, Lindgren LM, Pehrson C. Life-threatening vaginal bleeding after starting rivaroxaban treatment. Ugeskrift for Læger. 2024. doi:10.61409/v01240012
BibTeX
@article{Ekenberg2024,
author = {Ekenberg, Luna Fabricius and Lindgren, Line Markdanner and Pehrson, Caroline},
title = {Life-threatening vaginal bleeding after starting rivaroxaban treatment},
journal = {Ugeskrift for Læger},
year = {2024},
doi = {10.61409/v01240012}
}
EUVIMED